New syringe for eye disease injections passes usability test

NCT ID NCT07501052

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether doctors could safely and correctly use a new prefilled syringe (SCD411) for eye injections. It included 33 adults with wet age-related macular degeneration, retinal vein occlusion, diabetic macular edema, or diabetic retinopathy. The main goal was to see if doctors could complete tasks like opening, injecting, and disposing of the syringe without errors. This was not a treatment study—it focused on how easy and safe the device is to use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic macular edema diabetic retinopathy macular degeneration retinal vein occlusion wet macular degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Center for Retina and Macular Disease

    Winter Haven, Florida, 33880, United States

  • East Florida Eye Institute

    Stuart, Florida, 34994, United States

  • Retina Vitreous Surgeons of Central New York, PC

    Liverpool, New York, 13088, United States

  • University Retina & Macula Associates, P.C

    Lemont, Illinois, 60439, United States